ESTRO 35 2016 _____________________________________________________________________________________________________ of treatment. Patients treated with TUR-B followed by radiotherapy were significantly older compared to patients with cystectomy before radiotherapy and were less likely to receive chemotherapy. There was no significant difference for the length of the interval between first treatment and radiotherapy for the three groups. Despite of this, type of surgical procedure before radiotherapy did not show an impact on overall survival (p = 0.86).
Results:
Records of 93 patients were available. Median age at time of LND was 65.3 years (range 35.9-90.2 years). Median follow up was 9.4 months . The median number of involved ILNs was 4 (range 1-12), and median PLNs positive was 2 (range 1-21). 72% of patients had ECE in the inguinal area and 49% had ECE in the pelvis. Infield failure occurred in 26/87 sites with ECE and 8/64 sites without ECE (p = 0.015). In the presence of ECE, patients receiving RT experienced infield failure in 17/50 cases and in 10/38 patients not receiving RT (P=NS). Absent ECE, patients failed infield in 5/40 cases after RT and 3/24 cases without RT (p=NS). RT was not associated with improved OS (p=0.073) or recurrence (p=0.492) on multivariate analysis. Chemotherapy was significant on multivariate analysis for recurrence (p = 0.009) but not survival (p=0.334). Results: after a median follow-up of 10 months (range 0 -36 months) 20 patients were alive. Ten patients received SRT alone and 13 patients received that during the maximal response of systemic therapy. The median equivalent of the dose (EQD2) was 50.6 Gy delivered with a median of 2.7 fractions (range 1-5) and the median biological equivalent dose (BED) was 51 Gy assuming α/β = 10 for tumour. Six patients are lost in follow-up. Clinical and radiological response was thus evaluated in 17 patients and the their LC was 100% (57.1% of patients received SRT alone and the others patients are still undergoing systemic treatment. 27.7% of patients had more than 12 months follow-up and the LC was again 100%. ). Progression of disease in the other sites was observed in all cases. No toxicity was observed.
Conclusion

Conclusion:
SRT is a feasible approach that offer an excellent LC with low toxicity profile in the treatment management of oligometastatic patients with RCC with or without the association of systemic therapy. Further investigation is warranted to identify the patients who would probably benefit from this approach.
EP-1390
Cystoman in the prevention of acute radio-induced urinary toxicity in irradiated pelvic region E. D'Ippolito 
C.N.R., Institute of Biostructures and Bioimaging, Naples, Italy
Purpose or Objective: Acute urinary unwished effects of pelvic irradiation may impact on quality of life of patients undergoing radiation therapy on the pelvis. Neoplasms such endometrial, cervical, rectal, and anal cancer requires irradiation of relevant pelvic volumes. In this study we tested Cystoman, a dietary integrator of D-mannosium, cranberry and vitamin C, as prophylactic therapy for the development of acute urinary side effects.
Material and Methods:
Fifty five patients undergoing pelvic irradiation were randomly assigned to take 2 tablets/day of Cystomann or not from the beginning of radiation therapy. Radiation therapy consisted of 45 -50.4 Gy on the pelvis given by 1.8 Gy daily fractions with 3D conformal radiation therapy. The patients were weekly checked for urinary symptoms. Urine colture was performed before and after the treatment.
Results: Between November 2014 and September 2015, 55 consecutive patients were enrolled in the study. Median age was 65 year, 11 were affected by cervical cancer, 9 endometrial, 31 rectal, and 4 anal cancer. Twenty two patients were treated preoperatively and 33 postoperatively. Urinary toxicity appeared at the second week in 3/28 patients in Cystoman group and 11/27 in the control group (p= 0,02). However by the end of the treatment 8/28 and 13/27 patients had urinary toxicity in the Cystoman and control group, respectively (p=0.1).
Conclusion:
Our study suggests that Cystomann delays the radio-induced acute urinary toxicity presentation and could ameliorate the toxicity profile of the pelvic irradiation. 
University of Tokyo Hospital, Dermatology, Tokyo, Japan
Purpose or Objective: Description of three cases of total skin irradiation for cutaneous T-cell lymphoma using helical TomoTherapy (Accuray, Sunnyvale, CA).
Material and Methods:
In 2015, three patients with refractory T-cell lymphoma underwent total skin irradiation using invers-planned helical tomotherapy. The first case was a 25-year-old man diagnosed as mycosis fungoides with multiple tumors occurring on the extremities, face, and trunk. The second case was a 73-year-old woman diagnosed as primary cutaneous gamma delta T-cell lymphoma. She had received 24 Gy of irradiation in 12 fractions with total skin electron beam irradiation technique 10 years ago, and some parts of her skin were irradiated with 24 Gy in 12 fractions with local electron beam irradiation within 3 years. The third case was a 52-year-old man diagnosed as mycosis fungoides. No bolus was added around the body. Because of the long length of treatment of the body in TomoTherapy, treatments were delivered to three parts of the body (trunk, head and neck, and legs). Irradiation was not performed in two or three parts on the same day. Each plan was generated with a prescription dose of 10 Gy in 10 fractions. The planning target volume (PTV) was the body surface with 5mm margins of internal and external lesions of the skin. The third patient had several swelling lymph nodes, so the PTV was the body surface and swelled lymph nodes with their margins.
Results:
TomoTherapy technique was created that enabled delivery of the prescription dose to PTV with a relatively sharp drop-off of dose at depth. The calculated mean doses for the organs at risk were 1.96, 2.08, 2.12, 2.19, and 2.27 Gy for the lung, heart, liver, kidneys, and bones, respectively. Using the couch-indexed Vac-Lok cushion and head mask, inter-and intra-fractional patients motions were minimized. All three patients experienced edemas of fingers and toes, and lost much of their hair. Myelosuppression occurred in two of the three patients. Because of grade 4 myelosuppression, the second patient who was treated total skin electron beam irradiation 10 years ago, was treated with blood transfusion during the treatment. All tumors were reduced during and after the treatment.
Conclusion:
Using the TomoTherapy technique in total skin irradiation, we were able to achieve good coverage of the PTV and good sparing of organs at risk, including the bones. This treatment method, including the prescription dose and treatment duration, will be needed further research.
EP-1392
The abscopal effect:efficacy of radiotherapy in patients on progression after ipilimumab 3 mg/kg A.M. Grimaldi
